Better Buy: Teladoc vs. Livongo Health
The COVID-19 pandemic has provided a major boost to companies in the emerging field of remote healthcare. The use of technology to extend healthcare beyond the doors of clinics and hospitals was already a growing trend coming into 2020, but stay-at-home mandates and the prospect of health facilities being overwhelmed by coronavirus patients accelerated the pressure on medical systems to find ways to treat remotely those patients who could be. The companies delivering these services have seen demand grow quickly.
As you might expect, this phenomenon hasn't gone unnoticed by investors. Two companies that are in leading positions in their niches are Teladoc (NYSE: TDOC) and Livongo (NASDAQ: LVGO), and the shares of both have soared this year, by 171% and 352%, respectively.
After such big gains, are either of these stocks worthwhile investments, and, if so, which represents the best opportunity now?
Source Fool.com
